Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Pharmacological Treatments of Covid-19 Publisher Pubmed



Sahebnasagh A1 ; Avan R2 ; Saghafi F3 ; Mojtahedzadeh M4 ; Sadremomtaz A5 ; Arasteh O6 ; Tanzifi A7, 8 ; Faramarzi F9 ; Negarandeh R10 ; Safdari M11 ; Khataminia M12 ; Rezai Ghaleno H13 ; Habtemariam S14 ; Khoshi A15
Authors

Source: Pharmacological Reports Published:2020


Abstract

The viral infection due to the new coronavirus or coronavirus disease 2019 (COVID-19), which was reported for the first time in December 2019, was named by the World Health Organization (WHO) as Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV2), because of the very similar genome and also its related symptoms to SARS-CoV1. The ongoing COVID-19 pandemic with significant mortality, morbidity, and socioeconomic impact is considered by the WHO as a global public health emergency. Since there is no specific treatment available for SARS-CoV2 infection, and or COVID-19, several clinical and sub-clinical studies are currently undertaken to find a gold-standard therapeutic regimen with high efficacy and low side effect. Based on the published scientific evidence published to date, we summarized herein the effects of different potential therapies and up-to-date clinical trials. The review is intended to help readers aware of potentially effective COVID-19 treatment and provide useful references for future studies. © 2020, Maj Institute of Pharmacology Polish Academy of Sciences.
Other Related Docs
5. Novel Therapeutic Approaches for Treatment of Covid-19, Journal of Molecular Medicine (2020)
14. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)